【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 11
1.1 List of Tables 17
1.2 List of Figures 24
2 Introduction 26
2.1 Catalyst 26
2.2 Related Reports 28
2.3 Upcoming Related Reports 28
3 Disease Overview 29
3.1 Etiology and Pathophysiology 29
3.1.1 Etiology 29
3.1.2 Pathophysiology 31
3.2 Symptoms 35
3.3 Prognosis 35
3.4 Quality of Life 35
4 Epidemiology 36
4.1 Risk Factors and Comorbidities 36
4.2 Global and Historical Trends 37
4.2.1 US 38
4.2.2 5EU 38
4.2.3 Asia 40
4.3 Forecast Methodology 41
4.3.1 Sources Used 49
4.3.2 Forecast Assumptions and Methods 55
4.3.3 Sources Not Used 81
4.4 Prevalent Cases of Dyslipidemia 82
4.4.1 Total Prevalent Cases of Dyslipidemia 82
4.4.2 Age-Specific Total Prevalent Cases of Dyslipidemia 83
4.4.3 Sex-Specific Total Prevalent Cases of Dyslipidemia 85
4.4.4 Age-Standardized Total Prevalence of Dyslipidemia 87
4.5 Epidemiological Forecast for Familial Hypercholesterolemia (2013-2023) 88
4.5.1 Total Prevalent Cases of Familial Hypercholesterolemia 88
4.6 Epidemiological Forecast for Increased LDL-C (2013-2023) 89
4.6.1 Total Prevalent Cases of Increased LDL-C 89
4.6.2 Age-Specific Total Prevalent Cases of Increased LDL-C 91
4.6.3 Sex-Specific Total Prevalent Cases of Increased LDL-C 93
4.6.4 Age-Standardized Total Prevalence of Increased LDL-C 95
4.7 Epidemiological Forecast for Very High TG (≥500mg/dL) (2013-2023) 96
4.7.1 Total Prevalent Cases of Very High TG (≥500mg/dL) 96
4.7.2 Age-Specific Total Prevalent Cases of Very High TG (≥500mg/dL) 98
4.7.3 Sex-Specific Total Prevalent Cases of Very High TG (≥500mg/dL) 100
4.7.4 Age-Standardized Total Prevalence of Very High TG (≥500mg/dL) 102
4.8 Discussion 103
4.8.1 Epidemiological Forecast Insight 103
4.8.2 Limitations of the Analysis 104
4.8.3 Strengths of the Analysis 105
5 Disease Management 106
5.1 Diagnosis and Treatment Overview 106
5.1.1 Diagnosis 106
5.1.2 Treatment Guidelines and Leading Prescribed Drugs 108
5.1.3 Clinical Practice 111
5.2 US 113
5.3 France 117
5.4 Germany 119
5.5 Italy 122
5.6 Spain 125
5.7 UK 126
5.8 Japan 129
5.9 China 131
6 Competitive Assessment 134
6.1 Overview 134
6.2 Product Profiles – Major Brands 138
6.2.1 Statins 138
6.2.2 Zetia (ezetimibe) 158
6.2.3 Vytorin (simvastatin/ezetimibe) 167
6.2.4 Liptruzet (atorvastatin/ezetimibe) 171
6.2.5 Niaspan (niacin extended-release) 175
6.2.6 Kynamro (mipomersen sodium) 181
6.2.7 Juxtapid (lomitapide) 188
6.2.8 TriCor/Trilipix (fenofibrate/fenfibric acid) 193
6.2.9 Omega-3 Fatty Acids 198
6.2.10 Welchol (colesevelam HCl) and the Bile Acid Sequestrants 213
7 Unmet Need and Opportunity 219
7.1 Overview 219
7.2 LDL-C-Lowering Drugs for Statin-Intolerant and Statin-Refractory Patients 220
7.2.1 Unmet Need 220
7.2.2 Gap Analysis 221
7.2.3 Opportunity 222
7.3 Improved Diagnosis, Patient Education, and Long-term Compliance 223
7.3.1 Unmet Need 223
7.3.2 Gap Analysis 224
7.3.3 Opportunity 226
7.4 Therapies that Prevent or Reverse the Build-Up of Atherosclerotic Plaque 227
7.4.1 Unmet Need 227
7.4.2 Gap Analysis 228
7.4.3 Opportunity 229
7.5 Therapies for Patients with HoFH with Improved Side Effect Profiles 230
7.5.1 Unmet Need 230
7.5.2 Gap Analysis 231
7.5.3 Opportunity 232
8 Pipeline Assessment 233
8.1 Overview 233
8.2 Clinical Trial Mapping 237
8.2.1 Clinical Trials by Patient Population 237
8.3 Promising Drugs in Clinical Development 237
8.3.1 Alirocumab 237
8.3.2 Bococizumab 246
8.3.3 Evolocumab 251
8.3.4 Anacetrapib 260
8.3.5 Evacetrapib 268
8.3.6 TA-8995 (DEZ-001) 274
8.3.7 CER-001 280
8.3.8 ETC-1002 286
8.4 Other Drugs in Development 294
9 Current and Future Players 295
9.1 Overview 295
9.2 Trends in Corporate Strategy 300
9.3 Company Profiles 302
9.3.1 AbbVie 302
9.3.2 Aegerion Pharmaceuticals, Inc. 304
9.3.3 Amarin 306
9.3.4 Amgen 308
9.3.5 AstraZeneca 310
9.3.6 Cerenis Therapeutics Inc. 313
9.3.7 Daiichi Sankyo 315
9.3.8 Dezima Pharma 317
9.3.9 Eli Lilly 319
9.3.10 Esperion Therapeutics, Inc. 322
9.3.11 Genzyme 324
9.3.12 GlaxoSmithKline 326
9.3.13 Merck & Co. 328
9.3.14 Pfizer 331
9.3.15 Regeneron Pharmaceuticals, Inc. 333
9.3.16 Sanofi 335
10 Market Outlook 339
10.1 Global Markets 339
10.1.1 Forecast 339
10.1.2 Drivers and Barriers – Global Issues 348
10.2 United States 351
10.2.1 Forecast 351
10.2.2 Key Events 356
10.2.3 Drivers and Barriers 357
10.3 5EU 359
10.3.1 Forecast 359
10.3.2 Key Events 367
10.3.3 Drivers and Barriers 368
10.4 Japan 371
10.4.1 Forecast 371
10.4.2 Key Events 374
10.4.3 Drivers and Barriers 375
10.5 China 377
10.5.1 Forecast 377
10.5.2 Key Events 381
10.5.3 Drivers and Barriers 381
11 Appendix 384
11.1 Bibliography 384
11.2 Abbreviations 412
11.3 Methodology 420
11.4 Forecasting Methodology 420
11.4.1 Diagnosed Dyslipidemia Patients 420
11.4.2 Percent Drug-Treated Patients 421
11.4.3 Drugs Included in Each Therapeutic Class 421
11.4.4 Launch and Patent Expiry Dates 422
11.4.5 General Pricing Assumptions 423
11.4.6 Individual Drug Assumptions 424
11.4.7 Generic Erosion 431
11.4.8 Pricing of Pipeline Agents 431
11.5 Physicians and Specialists Included in this Study 432
11.6 About the Authors 434
11.6.1 Analyst 434
11.6.2 Therapy Area Director 435
11.6.3 Epidemiologist 435
11.6.4 Global Head of Healthcare 436
11.7 About GlobalData 437
11.8 Disclaimer 437
【レポート販売概要】
■ タイトル：脂質異常症治療薬の世界市場予測および分析■ 英文：PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2023
■ 発行日：2015年5月5日
■ 調査会社：GlobalData
■ 商品コード：GDHC110PIDR
■ 調査対象地域：グローバル
- 産業用ワイヤレスオートメーションの世界市場2019-2023About this market Wireless technologies have evolved over the years to simplify business operations across the end-user industries. Advances in wireless solutions have empowered end-users to deploy M2M services for managing several facets of business. The major factor driving the M2M communications is the pervasive accessibility of low cost, ubiquitous connectivity. M2M, in general, is a next-gene …
- 熱伝達流体の世界市場2016-2020About Heat Transfer Fluids Heat transfer fluids have a varied range of applications in industries that function in the extreme temperature ranges such as the chemical, solar power, plastics and polymers, and oil and gas industries. Numerous kinds of heat transfer fluids are used in the industries depending upon their applications. Some of them are silicone and aromatics, glycol-based fluids, miner …
- ヒト・マイクロバイオームの世界市場：プロバイオティクス、食品、プレバイオティクス、医療食品、診断デバイス、医薬品、サプリメントThe human microbiome market is segmented by application, disease, product, and geography while the human microbiome research spending market is broadly segmented by product and technology. The human microbiome market is expected to reach USD 658 Million by 2023 from USD 294 Million in 2019 growing at a CAGR of 22.3% during the forecast period (2019–2023). The market is driven by growing incidences …
- スマートホーム市場（グローバル市場分析と予測）Smart homes refers to a residence equipped with computing and information technology devices that anticipate and respond to the needs of the residents; thus, working towards enhancing their comfort, convenience, security, and entertainment through the upgradation of technology within the home. The concept of smart homes has been in the picture for a long time; such homes have always been a dream o …
- アメリカの仮想・遠隔実験室市場2016-2020About the Virtual and Remote Laboratories Market Virtual laboratories are set up on an online platform and are used to create simulation of a science process or explanation of a subject. Advanced computer languages, such as MatLab and LabView, are used to develop these laboratories. They offer anywhere, anytime access to experiments and are designed for a specific subject or a course. Through this …
- 嫌気消化の世界市場展望2017-20276According to Stratistics MRC, the Global Anaerobic Digestion Market is accounted for $6.45 billion in 2017 and is expected to reach $16.09 billion by 2026 growing at a CAGR of 10.7% during the forecast period. Some of the key factors influencing the market are raising focus toward sustainable energy coupled with measures to reduce greenhouse gas emissions. However, high cost of investment in large …
- 酒石酸の世界市場2015-2019Technavio’s market research analyst predicts the global tartaric acid market to grow at a moderate rate of around 4% during the forecast period. The growth of the food and beverages industry due to the rising demand for packaged food is driving the growth of this market. The rise in disposable income coupled with the growing middle-class population in the BRIC countries is also contributing to the …
- 動物用ワクチン（Veterinary vaccine）の世界市場機会分析Veterinary vaccines are a fast growing component of the overall animal health market which itself was worth approximately $24bn/yr in 2013. Key segments are vaccines for companion animals such as the canine and feline markets along with livestock, pigs and poultry. Veterinary vaccines are attractive commercially due to population growth and an increased demand for animal protein as a food source e …
- ヘルペス治療薬の世界市場：口唇ヘルペス、陰部ヘルペスAbout Herpes Generally, herpes covers two different diseases: oral herpes, also known as cold sores and genital herpes. While oral herpes affects the area around the mouth, genital herpes affects area around the genitals. The HSV-1 causes oral herpes; both HSV-1 and HSV-2 cause genital herpes. HSV is a contagious virus that spread through contact. At present, there is no cure for herpes, however, …
- Calvalley Petroleum Inc.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Calvalley Petroleum Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Calvalley Petroleum Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- イギリスの感染症検査市場2014This report provides an overview of the UK infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Table of ContentsBusiness EnvironmentMarket Structure Market Size, Growth, and Major Suppliers' Market SharesList of Tables …
- クラウド基盤給与計算ソフトの世界市場2016-2020About Cloud-Based Payroll Software In HR, the payroll department is critical as employees are sensitive to payroll errors and irregularities. The key task of the payroll department is to ensure that all the employees are paid accurately and appropriately after the correct deductions. In addition, with the use of the payroll software, the HR team can track the number of hours each employee has work …
- オート麦スナックの世界市場2017-2021：ベーカリー・バー、セイボリースナックAbout Oat-based Snacks Oat-based snacks are becoming increasingly popular across the globe. Companies are strategizing on launching innovative flavors of oat-based snacks, like cookies, bars, cakes, or savory snacks, to extend their consumer base, which will in return help them augment their respective market shares. As per Technavio's analysis, the market will be predominantly dominated by the pr …
- 食品ナノテクノロジーの世界市場2019-2023About this market The global rise in population is one significant factor propelling the need for techniques to improve agricultural productivity. The rapid growth in population would encourage increased adoption of novel nanotechnology tools to boost agricultural productivity. This factor would be a significant growth factor for the global food nanotechnology market over the forecast period. Tech …
- 植物成長調整剤（PGR）の世界市場：オーキシン、サイトカイニン、ジベレリンThe plant growth regulators market is projected to grow at a CAGR of 3.6% from 2015 to reach a projected value of USD 1.91 Billion by 2020. The market growth is driven by growing customer attention towards enhancing the premium value of fruits, vegetables, ornamentals and other permanent crops. The market is further driven by factors such as technology and product development of innovative plant g …
